These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 33822472)
1. Longevity of the novel ConvaTec infusion set with Lantern technology. Lal RA; Hsu L; Zhang J; Schøndorff PK; Heschel M; Buckingham B Diabetes Obes Metab; 2021 Aug; 23(8):1973-1977. PubMed ID: 33822472 [TBL] [Abstract][Full Text] [Related]
2. Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique. Simic A; Schøndorff PK; Stumpe T; Heschel M; Regittnig W; Pöttler T; Ninaus D; Augustin T; Groselj-Strele A; Pieber TR; Mader JK Diabetes Obes Metab; 2021 Jun; 23(6):1402-1408. PubMed ID: 33528887 [TBL] [Abstract][Full Text] [Related]
3. Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes. Kastner JR; Venkatesh N; Brown K; Muchmore DB; Ekinci E; Fourlanos S; Joseph JI; Shafeeq M; Shi L; Strange P; Strasma PJ; O'Neal DN Diabetes Obes Metab; 2022 Jun; 24(6):1143-1149. PubMed ID: 35257468 [TBL] [Abstract][Full Text] [Related]
4. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E; Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468 [TBL] [Abstract][Full Text] [Related]
6. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. Rubin RR; Peyrot M J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395 [TBL] [Abstract][Full Text] [Related]
7. In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time. Kastner JR; Eisler G; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Strasma PJ; Joseph JI J Diabetes Sci Technol; 2023 Nov; 17(6):1563-1572. PubMed ID: 35533132 [TBL] [Abstract][Full Text] [Related]
8. Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies. Kastner JR; Poettler T; Kopanz J; Hochfellner DA; Romey M; Baumann PM; Muchmore D; Strasma PJ; Mader JK Diabetes Obes Metab; 2023 Apr; 25(4):1106-1111. PubMed ID: 36482830 [No Abstract] [Full Text] [Related]
9. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3. Schmid V; Hohberg C; Borchert M; Forst T; Pfützner A J Diabetes Sci Technol; 2010 Jul; 4(4):976-82. PubMed ID: 20663464 [TBL] [Abstract][Full Text] [Related]
10. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142 [TBL] [Abstract][Full Text] [Related]
11. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899 [TBL] [Abstract][Full Text] [Related]
13. Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review. Zhang G; Romo-Anselmo E; Kwa T; Cohen O; Vigersky R; Chattaraj S J Diabetes Sci Technol; 2023 Mar; 17(2):302-313. PubMed ID: 36562593 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of infusion set function: steel versus teflon. Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124 [TBL] [Abstract][Full Text] [Related]
15. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control. Waldenmaier D; Zschornack E; Buhr A; Pleus S; Haug C; Freckmann G Diabetes Technol Ther; 2020 Oct; 22(10):734-741. PubMed ID: 32167382 [No Abstract] [Full Text] [Related]
16. Development of the Extended Infusion Set and Its Mechanism of Action. Zhang G; Cohen O; Chattaraj S J Diabetes Sci Technol; 2024 Mar; 18(2):454-459. PubMed ID: 35876264 [TBL] [Abstract][Full Text] [Related]
17. Progressive Acceleration of Insulin Exposure Over 7 Days of Infusion Set Wear. Kastner JR; Bailey TS; Strange P; Shi L; Oberg KA; Strasma PJ; Joseph JI; Muchmore DB Diabetes Technol Ther; 2023 Feb; 25(2):143-147. PubMed ID: 36342853 [TBL] [Abstract][Full Text] [Related]
18. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709 [TBL] [Abstract][Full Text] [Related]